PRECISION BIOSCIENCES (DTIL) stock: insider trades, news & valuation
Health Care · Net sellingShare price and insider trades
PRECISION BIOSCIENCES insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $43K and 4 sold $466K of DTIL stock on the open market.
Get emailed when insiders cluster-buy stocks like DTIL
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
DTIL insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $30K | 3 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $431K | 8 |
| Q4 2025 | $34K | 3 | $35K | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 PRECISION BIOSCIENCES INC insiders reported open-market purchases totaling $43K, while 4 insiders reported sales totaling $466K. Among insiders with enough purchase history to measure, Geno J Germano (Director) has the highest Insider Score at 45. 11 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
DTIL stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 30SEC | Stanley FrankelDirector | Buy | 1,00041,478 held (+2%) | $6.00 | $6K | +12.0% | — |
| Sep 29SEC | Geno J GermanoDirector | Buy | 2,60947,492 held (+6%) | $6.28 | $16K | +7.0% | 45 |
| Sep 29SEC | Melinda BrownDirector | Buy | 1,13545,481 held (+3%) | $6.27 | $7K | +7.2% | — |
| Feb 19SEC | Michael AmorosoCEO, President | Sell Plan | 20,559243,392 held (−8%) | $3.84 | $79K | +75.0% | — |
| Feb 19SEC | John Alexander KellyCFO | Sell Plan | 8,149125,883 held (−6%) | $3.84 | $31K | +75.0% | — |
| Feb 19SEC | J. Jefferson SmithChief Research Officer | Sell Plan | 4,925121,926 held (−4%) | $3.84 | $19K | +75.0% | — |
| Feb 19SEC | Dario ScimecaGeneral Counsel | Sell Plan | 4,92556,457 held (−8%) | $3.84 | $19K | +75.0% | — |
| Jan 22SEC | Michael AmorosoCEO, President | Sell Plan | 34,799196,154 held (−15%) | $4.17 | $145K | +61.2% | — |
| Jan 22SEC | John Alexander KellyCFO | Sell Plan | 15,213106,448 held (−13%) | $4.03 | $61K | +66.7% | — |
| Jan 22SEC | J. Jefferson SmithChief Research Officer | Sell Plan | 10,200110,184 held (−8%) | $4.03 | $41K | +66.7% | — |
| Jan 22SEC | Dario ScimecaGeneral Counsel | Sell Plan | 8,85444,715 held (−17%) | $4.03 | $36K | +66.7% | — |
| Dec 17SEC | Geno J GermanoDirector | Buy | 3,00023,883 held (+14%) | $4.72 | $14K | +42.4% | 45 |
| Dec 17SEC | Stanley FrankelDirector | Buy | 2,70019,478 held (+16%) | $4.70 | $13K | +43.0% | — |
| Dec 17SEC | Melinda BrownDirector | Buy | 1,38123,346 held (+6%) | $4.97 | $7K | +35.2% | — |
| Nov 4SEC | Michael AmorosoCEO, President | Sell Plan | 3,409115,575 held (−3%) | $6.49 | $22K | +3.5% | — |
| Nov 4SEC | John Alexander KellyCFO | Sell Plan | 1,30377,298 held (−2%) | $6.49 | $8K | +3.5% | — |
| Nov 4SEC | Dario ScimecaGeneral Counsel | Sell Plan | 66528,258 held (−2%) | $6.49 | $4K | +3.5% | — |
Insiders at PRECISION BIOSCIENCES INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Michael AmorosoCEO, President | — | $246K | Feb 19, 2026 | — |
| John Alexander KellyCFO | — | $101K | Feb 19, 2026 | — |
| Geno J GermanoDirector | $31K | — | Sep 29, 2026 | 45 |
| J. Jefferson SmithChief Research Officer | — | $60K | Feb 19, 2026 | — |
| Dario ScimecaGeneral Counsel | — | $59K | Feb 19, 2026 | — |
| Stanley FrankelDirector | $19K | — | Sep 30, 2026 | — |
| Melinda BrownDirector | $14K | — | Sep 29, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
DTIL stock: common questions
Are PRECISION BIOSCIENCES INC insiders buying DTIL stock?
In the past 12 months, 2 insiders reported open-market purchases of DTIL worth $43K. The latest was Director Stanley Frankel bought $6K of DTIL at $6.00.
Are PRECISION BIOSCIENCES INC insiders selling DTIL stock?
4 insiders reported sales worth $466K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is DTIL's 52-week range?
Over the past year DTIL has traded between $3.57 and $9.28. It last closed at $6.72 on Oct 9, 2026.